322 related articles for article (PubMed ID: 24714633)
1. Beta-blockers in liver cirrhosis.
Giannelli V; Lattanzi B; Thalheimer U; Merli M
Ann Gastroenterol; 2014; 27(1):20-26. PubMed ID: 24714633
[TBL] [Abstract][Full Text] [Related]
2. Review article: controversies surrounding the use of carvedilol and other beta blockers in the management of portal hypertension and cirrhosis.
Gillespie SL; Hanrahan TP; Rockey DC; Majumdar A; Hayes PC
Aliment Pharmacol Ther; 2023 Mar; 57(5):454-463. PubMed ID: 36691947
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic Response to Carvedilol is Maintained for Long Periods and Leads to Better Clinical Outcome in Cirrhosis: A Prospective Study.
Kirnake V; Arora A; Gupta V; Sharma P; Singla V; Bansal N; Goyal M; Chawlani R; Kumar A
J Clin Exp Hepatol; 2016 Sep; 6(3):175-185. PubMed ID: 27746613
[TBL] [Abstract][Full Text] [Related]
4. The 35-year odyssey of beta blockers in cirrhosis: any gender difference in sight?
Burza MA; Marschall HU; Napoleone L; Molinaro A
Pharmacol Res; 2017 May; 119():20-26. PubMed ID: 28099882
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Oesophageal Varices in Liver Cirrhosis.
Sauerbruch T; Wong F
Digestion; 2019; 99(4):261-266. PubMed ID: 30212817
[TBL] [Abstract][Full Text] [Related]
6. Carvedilol as the new non-selective beta-blocker of choice in patients with cirrhosis and portal hypertension.
Turco L; Reiberger T; Vitale G; La Mura V
Liver Int; 2023 Jun; 43(6):1183-1194. PubMed ID: 36897563
[TBL] [Abstract][Full Text] [Related]
7. Primary prophylaxis of variceal bleeding in patients with cirrhosis: A comparison of different strategies.
de Mattos ÂZ; Terra C; Farias AQ; Bittencourt PL;
World J Gastrointest Endosc; 2021 Dec; 13(12):628-637. PubMed ID: 35070024
[TBL] [Abstract][Full Text] [Related]
8. Risk and Predictors of Variceal Bleeding in Cirrhosis Patients Receiving Primary Prophylaxis With Non-Selective Beta-Blockers.
Shukla R; Kramer J; Cao Y; Ying J; Tansel A; Walder A; Advani S; El-Serag HB; Kanwal F
Am J Gastroenterol; 2016 Dec; 111(12):1778-1787. PubMed ID: 27670600
[TBL] [Abstract][Full Text] [Related]
9. Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleeding.
Pfisterer N; Dexheimer C; Fuchs EM; Bucsics T; Schwabl P; Mandorfer M; Gessl I; Sandrieser L; Baumann L; Riedl F; Scheiner B; Pachofszky T; Dolak W; Schrutka-Kölbl C; Ferlitsch A; Schöniger-Hekele M; Peck-Radosavljevic M; Trauner M; Madl C; Reiberger T
Aliment Pharmacol Ther; 2018 Apr; 47(7):966-979. PubMed ID: 29388229
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varices.
Paternostro R; Becker J; Hofer BS; Panagl V; Schiffke H; Simbrunner B; Semmler G; Schwabl P; Scheiner B; Bucsics T; Bauer D; Binter T; Trauner M; Mandorfer M; Reiberger T
Dig Liver Dis; 2022 Apr; 54(4):500-508. PubMed ID: 34799282
[TBL] [Abstract][Full Text] [Related]
11. Variceal and other portal hypertension related bleeding.
Turon F; Casu S; Hernández-Gea V; Garcia-Pagán JC
Best Pract Res Clin Gastroenterol; 2013 Oct; 27(5):649-64. PubMed ID: 24160925
[TBL] [Abstract][Full Text] [Related]
12. The Efficacy of Carvedilol in Comparison to Propranolol in Reducing the Hepatic Venous Pressure Gradient and Decreasing the Risk of Variceal Bleeding in Adult Cirrhotic Patients: A Systematic Review.
Dardari L; Taha M; Dahat P; Toriola S; Satnarine T; Zohara Z; Adelekun A; Seffah KD; Salib K; Arcia Franchini AP
Cureus; 2023 Aug; 15(8):e43253. PubMed ID: 37577269
[TBL] [Abstract][Full Text] [Related]
13. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol.
Reiberger T; Ulbrich G; Ferlitsch A; Payer BA; Schwabl P; Pinter M; Heinisch BB; Trauner M; Kramer L; Peck-Radosavljevic M;
Gut; 2013 Nov; 62(11):1634-41. PubMed ID: 23250049
[TBL] [Abstract][Full Text] [Related]
14. Propranolol plus endoscopic ligation for variceal bleeding in patients with significant ascites: Propensity score matching analysis.
Yoo JJ; Kim SG; Kim YS; Lee B; Jeong SW; Jang JY; Lee SH; Kim HS; Jun BG; Kim YD; Cheon GJ
Medicine (Baltimore); 2020 Jan; 99(5):e18913. PubMed ID: 32000397
[TBL] [Abstract][Full Text] [Related]
15. Beta-blockers for prophylaxis of bleeding from esophageal varices in cirrhotic portal hypertension. Review of the literature.
Zoller WG; Gross M
Eur J Med Res; 1996 Jun; 1(9):407-16. PubMed ID: 9353240
[TBL] [Abstract][Full Text] [Related]
16. The longitudinal outcomes of applying non-selective beta-blockers in portal hypertension: real-world multicenter study.
Kang SH; Lee M; Kim MY; Lee JH; Jun BG; Kim TS; Choi DH; Suk KT; Kim YD; Cheon GJ; Kim DJ; Baik SK
Hepatol Int; 2021 Apr; 15(2):424-436. PubMed ID: 33860898
[TBL] [Abstract][Full Text] [Related]
17. Combined therapies versus monotherapies for the first variceal bleeding in patients with high-risk varices: a meta-analysis of randomized controlled trials.
Bai M; Qi X; Yang M; Han G; Fan D
J Gastroenterol Hepatol; 2014 Mar; 29(3):442-52. PubMed ID: 24118091
[TBL] [Abstract][Full Text] [Related]
18. Carvedilol Versus Other Nonselective Beta Blockers for Variceal Bleeding Prophylaxis and Death: A Network Meta-analysis.
Cheung KS; Mok CH; Lam LK; Mao XH; Mak LY; Seto WK; Yuen MF
J Clin Transl Hepatol; 2023 Oct; 11(5):1143-1149. PubMed ID: 37577228
[TBL] [Abstract][Full Text] [Related]
19. Complications of cirrhosis. I. Portal hypertension.
Bosch J; García-Pagán JC
J Hepatol; 2000; 32(1 Suppl):141-56. PubMed ID: 10728801
[TBL] [Abstract][Full Text] [Related]
20. The portal hypertension syndrome: etiology, classification, relevance, and animal models.
Bosch J; Iwakiri Y
Hepatol Int; 2018 Feb; 12(Suppl 1):1-10. PubMed ID: 29064029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
